Blueprint Medicines Total Liabilities and Share Holders Equity 2014-2024 | BPMC

Blueprint Medicines total liabilities and share holders equity for the quarter ending September 30, 2024 was $1.200B, a 8.54% increase year-over-year.

  • Blueprint Medicines total liabilities and share holders equity for 2023 was $1.049B, a 22.27% decline from 2022.
  • Blueprint Medicines total liabilities and share holders equity for 2022 was $1.35B, a 7.8% increase from 2021.
  • Blueprint Medicines total liabilities and share holders equity for 2021 was $1.252B, a 27.13% decline from 2020.

Blueprint Medicines Total Liabilities and Share Holders Equity 2014-2024 | BPMC

  • Blueprint Medicines total liabilities and share holders equity for 2023 was $1.049B, a 22.27% decline from 2022.
  • Blueprint Medicines total liabilities and share holders equity for 2022 was $1.35B, a 7.8% increase from 2021.
  • Blueprint Medicines total liabilities and share holders equity for 2021 was $1.252B, a 27.13% decline from 2020.